Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

ClinicalTrials.gov ID: NCT04154072

Public ClinicalTrials.gov record NCT04154072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment With NLY01 in Early-stage Parkinson's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2 study designed to assess the safety, tolerability and efficacy of NLY01 in subjects with early untreated Parkinson's disease (PD). Evidence suggests NLY01, a pegylated form of exenatide, may be beneficial in PD and is being developed as a potential treatment for neurodegenerative disorders.

Study identification

NCT ID
NCT04154072
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Neuraly, Inc.
Industry
Enrollment
255 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 27, 2020 (Actual)
Primary completion
Feb 14, 2023 (Actual)
Completion
Feb 14, 2023 (Actual)
Last update posted
Sep 19, 2024

2020 – 2023

United States locations

U.S. sites
60
U.S. states
27
U.S. cities
52
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
St. Joseph's Hospital and Medical Center - Barrow Neurological Institute Phoenix Arizona 85013 —
Movement Disorders Center Scottsdale Arizona 85258 —
Mayo Clinic Arizona, Mayo Clinic Scottsdale Scottsdale Arizona 85259 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
University of California, Irvine Irvine California 92697 —
Keck School of Medicine of USC/University of Southern California Los Angeles California 90033 —
University of California, Los Angeles, Center for Neurotherapeutics Los Angeles California 90095 —
SC3 Research Pasadena California 91105 —
University of California Davis Health Sacramento California 95816 —
University of California, San Francisco San Francisco California 94143 —
University of Colorado Denver Colorado 80204 —
Rocky Mountain Movement Disorder Center Englewood Colorado 80113 —
Institute for Neurodegenerative Disorders New Haven Connecticut 06510 —
Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Parkinson's Disease and Movement Disorder Center Boca Raton Florida 33486 —
Nova Clinical Research Bradenton Florida 34209 —
University of Florida Gainesville Florida 32608 —
Infinity Clinical Research Hollywood Florida 33024 —
Mayo Clinic Florida Jacksonville Florida 32224 —
Visionary Investigators Network Miami Florida 33133 —
University of Miami Miami Florida 33136 —
Renstar Medical Research Ocala Florida 34470 —
University of South Florida Tampa Florida 33613 —
Charter Research Winter Park Florida 32159 —
Augusta University Augusta Georgia 30912 —
NeuroStudies Decatur Georgia 30033 —
Northwestern Medical Group Neurology Clinic Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
SIU Medicine Springfield Illinois 62702 —
University of Kansas Medical Center Kansas City Kansas 66160 —
University of Maryland, Neurology Ambulatory Center, Maryland Parkinson's Disease and Movement Disorder Center Baltimore Maryland 21201 —
Johns Hopkins University School of Medicine Baltimore Maryland 21287 —
Massachusetts General Hospital Clinical Trials Pharmacy Boston Massachusetts 02114 —
Boston University Medical Center Boston Massachusetts 02118 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University of Michigan Hospital Ann Arbor Michigan 48109 —
Quest Research Institute Farmington Hills Michigan 48334 —
Henry Ford West Bloomfield Hospital West Bloomfield Michigan 48322 —
Struthers Parkinson's Center Golden Valley Minnesota 55427 —
University of Minnesota Delaware Clinical Research Unit Minneapolis Minnesota 55414 —
Neurology Specialists of Monmouth County West Long Branch New Jersey 07764 —
NYU Langone Medical Center, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders New York New York 10017 —
Neurological Institute, Columbia University Medical Center New York New York 10032 —
UNC CTRC Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27705 —
Raleigh Neurology Raleigh North Carolina 27607 —
Wake Forest Baptist Health Sciences Winston-Salem North Carolina 27157 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
University of Toledo, Gardner-McMaster Parkinson Center Toledo Ohio 43614 —
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136 —
Oregon Health and Science University Portland Oregon 97239 —
University of Pennsylvania Philadelphia Pennsylvania 19107 —
Rhode Island Hospital Providence Rhode Island 02903 —
Baylor College of Medicine Houston Texas 77030 —
University of Virginia Charlottesville Virginia 22908 —
Booth Gardner Parkinson's Care Center Kirkland Washington 98034 —
Froedtert Hospital Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04154072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04154072 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →